Moderna Readies for Full Vaccine Approval, as Pfizer Submits Data on Booster Shot
Right now, Moderna vaccine only authorized for emergency use in Americans 18+ years; Pfizer boosters available to immunocompromised
Record High COVID-19 Cases and Deaths Reported in Florida
As of Tuesday, Florida had reported a record average of 227 COVID-19 deaths a day this week
WHO Team Says Search for Coronavirus Origins at Standstill
Agency published an analysis in March that concluded the virus likely jumped to humans from animals
Some High-Priority Groups More Likely to Stop Taking PrEP
Younger individuals, African American and Latinx, those with substance use disorders more likely to discontinue PrEP
Current, Recent SARS-CoV-2 Infection May Up VTE Risk After Surgery
Substudy of prospective cohort study shows link between SARS-CoV-2 infection and increased risk for postoperative venous thromboembolism
SARS-CoV-2 Shot Continues to Prevent Infection, Hospitalization With Delta Variant
SARS-CoV-2 infection rate and hospitalization rate 4.9 and 29.2 times higher for unvaccinated versus fully vaccinated persons
Risk for Bell Palsy Up 42 Days After First Dose of CoronaVac
Hong Kong study shows small increased risk after Sinovac Biotech vaccine, but no significantly increased risk after BNT162b2 vaccine
SARS-CoV-2 Antibodies ID’d in Breast Milk of Vaccinated Lactating Women
After the second dose of mRNA COVID-19 vaccine, breast milk levels of IgG(S1) increased and correlated with corresponding serum levels
SARS-CoV-2 Vaccine Effectiveness 66 Percent During Delta Predominance
Vaccine effectiveness for all three vaccines decreased from 91 percent in months preceding delta predominance
J&J Says Booster Shot Ups Immune Response to COVID-19
The Johnson & Johnson vaccine was not part of the government's initial booster plan, announced last week
